Global Vascular Embolization Devices Market Report 2024: Compound Annual Growth of 6.69% Forecast During 2023-2028 [Yahoo! Finance]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Yahoo! Finance
The global vascular embolization devices market is poised to witness substantial growth, predicted to increase by USD 735.35 million during the 2023-2028 period, with a CAGR of 6.69%. Factors contributing to the market expansion include the rising prevalence of vascular diseases, a surge in product innovation, and an increase in mergers and acquisitions activities within the sector. Sector Analysis: End-user and Product Differentiation The market has been segmented into different categories to provide an in-depth understanding of the landscape. By end-user, the market is categorized into hospitals, specialty clinics, and ambulatory surgical centers (ASCs), addressing varying needs across the healthcare spectrum. Product-wise, the market is bifurcated into coiling devices and non-coiling devices, which are pivotal in the treatment of vascular anomalies. This segmentation reflects the diversification and specialized development within the industry. Geographical Insights On th
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Here's Why Boston Scientific (BSX) is a Strong Momentum Stock [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Barclays PLC from $70.00 to $78.00. They now have an "overweight" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Citigroup Inc. from $79.00 to $85.00. They now have a "buy" rating on the stock.MarketBeat
- Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at JPMorgan Chase & Co. from $72.00 to $82.00. They now have an "overweight" rating on the stock.MarketBeat
BSX
Earnings
- 4/24/24 - Miss
BSX
Sec Filings
- 4/26/24 - Form 144
- 4/24/24 - Form 8-K
- 4/4/24 - Form 8-K
- BSX's page on the SEC website